Pfizer says its COVID-19 vaccine protection lasts at least six months

METRO PLUS

How police, other security agencies foiled abduction of 4 Plateau varsity students

Nigerian Security Agencies have prevented the abduction of about four students of the Plateau State University in Bokkos Local Government Area of...

Father kills 18-year-old son in Kano over missing palm oil

A resident of the Gwazaye Quarter in the Kumbotso Local Government Area of Kano State, Awaisu Nagyala, has allegedly beaten his 18-year-old...

Security guard invites robbers to rob employer

The Ondo State Police Command has arrested a security guard working at the S.A. Filling Station in Ondo town, Abiodun Osuntimehin, for...

Three killed as robbers attack bank in Delta

Armed robbers on Tuesday reportedly killed three persons when they attacked a bank in the Issele-Uku, Aniocha North Local Governments Area of...

Kidnapping: Court laments delay in Evans trial

Justice Oluwatoyin Taiwo of an Ikeja Special Offences Court has expressed worries over the delay in the trial of Chukwudumeme Onwuamadike, popularly...

Pfizer Inc and BioNTech’s COVID-19 vaccine is around 91% effective at preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months.

The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800.

While the new overall efficacy rate of 91.3% is lower than the 95% originally reported in November for its 44,000-person trial, a number of variants have become more prevalent around the world since then.

Pfizer Chief Executive Albert Bourla said the updated results, which include data on more than 12,000 people fully inoculated for at least six months, positions the drugmakers to submit for full U.S. regulatory approval.

The vaccine is currently authorized on an emergency basis by the U.S. Food and Drug Administration.

The trial data “provide the first clinical results that a vaccine can effectively protect against currently circulating variants, a critical factor to reach herd immunity and end this pandemic for the global population,” BioNTech Chief Executive Ugur Sahin said in a statement.

Experts fear that new variants of COVID-19 from South Africa and Brazil could be resistant to existing vaccines and treatment. More than 300 cases of the South African variant have been detected in more than 25 U.S. states and jurisdictions, federal data shows.

The vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and 95.3% effective in preventing severe disease as defined by the U.S. Food and Drug Administration.

There were also no serious safety concerns observed in trial participants up to six months after the second dose, the companies said.

They added that it was generally equally effective irrespective of age, race, gender or ethnicity and among participants with a variety of existing medical conditions.

“These data reinforce our view that we have some really potent vaccines,” said Danny Altmann, a professor of immunology at Britain’s Imperial College London, who was not involved in the Pfizer trial.

He said the effectiveness against the South African variant was “especially noteworthy,” since it showed the vaccine is likely to offer effective protection in real-world settings where several different coronavirus variants could be circulating.

The trial reviewed more than 900 confirmed cases of COVID-19, most of which were among participants who received a placebo.

The release of updated results comes on the heels of separate data that showed the vaccine is safe and effective in 12 to 15-year-olds, paving the way for the drugmakers to seek U.S. and European approval to use the shot in this age group within weeks.

(Additional reporting by Michael Erman in New York and Kate Kelland in London; editing by Peter Henderson, Edwina Gibbs and David Goodman)

Sources: CTV News

Sign up to FREE email alerts from Tribunepoint Weekly - Daily News

When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.

- Advertisement -

Read Also

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

How police, other security agencies foiled abduction of 4 Plateau varsity students

Nigerian Security Agencies have prevented the abduction of about four students of the Plateau State University in Bokkos Local Government Area of...

More clashes in Minnesota after police shoot, kill Black man

Police clashed with protesters for a second night in the Minneapolis suburb where an officer who authorities say apparently intended to fire...

Ontario’s hard-hit ICUs aren’t just running out of beds, but also doctors and nurses

As the third wave overtakes the province, with no sign of slowing down, Ontario’s hospitals are turning into war zones — and...

Air Canada, Canadian government reach agreement in $5.9-billion ‘liquidity program’

Air Canada and the federal government have reached an agreement on a $5.9-billion aid package that the company says will speed up...

Kidnap epidemic: Gunmen abduct 18 in Ogun, Oyo, Rivers, Imo, Katsina

*Kidnappers whisk Ogun doctor, nurse away, NMA expresses concern *Gunmen kidnap Imo monarch, five traditional chiefs, two...